Skip to main content

Table 2 The prevalence of malignant neoplasm family history among different clinicopathologic features of gastric cancer patients

From: Family history of malignant neoplasm and its relation with clinicopathologic features of gastric cancer patients

Clinicopathologic parameter

Number of total patients

Number of patientswith positive MN-FH, n (%)

Cramer’s V

χ 2

P-value

Sex

  

0.044

0.197

0.657

Male

76

28 (36.8)

   

Female

28

9 (32.1)

   

Ages, years

  

0.060

0.368

0.832

<45

22

9 (40.9)

   

45 to 60

39

13 (33.3)

   

>60

43

15 (34.9)

   

Histology

     

TUBa

19

5 (26.3)

0.109

 

0.776*

PORb

69

27 (39.1)

   

SIGc

10

3 (30.0)

   

MUCd

6

2 (33.3)

   
  1. *: Fisher's exact test.
  2. aTUB, tubular adenocarcinoma; bPOR, poorly differentiated adenocarcinoma; cSIG, signet-ring cell carcinoma; dMUC, mucinous adenocarcinoma.